154 related articles for article (PubMed ID: 38736925)
1. Case Report on Botulinum Toxin Treatment for Complex Regional Pain Syndrome in a Digit Reconstruction.
Rashaan R; Arkoumanis PT; Gakis C; Lyssiotis FA; Michalis J; Anagnostopoulos P; Stratakis K
Maedica (Bucur); 2024 Mar; 19(1):182-185. PubMed ID: 38736925
[No Abstract] [Full Text] [Related]
2. Complex Regional Pain Syndrome: A Comprehensive Review.
Taylor SS; Noor N; Urits I; Paladini A; Sadhu MS; Gibb C; Carlson T; Myrcik D; Varrassi G; Viswanath O
Pain Ther; 2021 Dec; 10(2):875-892. PubMed ID: 34165690
[TBL] [Abstract][Full Text] [Related]
3. Meta-Analysis of Effectiveness and Safety of Botulinum Toxin in the Treatment of Complex Regional Pain Syndrome.
Su YC; Hsieh PC; Guo YH; Lin YC
Life (Basel); 2022 Dec; 12(12):. PubMed ID: 36556403
[TBL] [Abstract][Full Text] [Related]
4. Intra-articular botulinum toxin injection in complex regional pain syndrome: Case report and review of the literature.
Bellon G; Venturin A; Masiero S; Del Felice A
Toxicon; 2019 Mar; 159():41-44. PubMed ID: 30660558
[TBL] [Abstract][Full Text] [Related]
5. Lumbar Sympathetic Block with Botulinum Toxin Type B for Complex Regional Pain Syndrome: A Case Study.
Choi E; Cho CW; Kim HY; Lee PB; Nahm FS
Pain Physician; 2015; 18(5):E911-6. PubMed ID: 26431145
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Botulinum Toxin in the Treatment of Neuropathic Pain: A Literature Review.
Dekhne A; Goklani HD; Doshi N; Baskara Salian R; Gandhi SK; Patel P
Cureus; 2023 Oct; 15(10):e46848. PubMed ID: 37954779
[TBL] [Abstract][Full Text] [Related]
7. Botulinum Toxin A: A Novel Therapeutic Modality for Upper Extremity Chronic Regional Pain Syndrome.
Lessard L; Bartow MJ; Lee J; Diaz-Abel J; Tessler OES
Plast Reconstr Surg Glob Open; 2018 Oct; 6(10):e1847. PubMed ID: 30534480
[TBL] [Abstract][Full Text] [Related]
8. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
Lang AM
Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
[TBL] [Abstract][Full Text] [Related]
9. Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation.
Intiso D; Basciani M; Santamato A; Intiso M; Di Rienzo F
Toxins (Basel); 2015 Jun; 7(7):2454-80. PubMed ID: 26134256
[TBL] [Abstract][Full Text] [Related]
10. Botulinum Toxin A Plays an Important Role in the Placement of Implants Deep Within the Pectoralis Major Muscle for Mammaplasty: A Systematic Review and Meta-analysis.
Li T; Liu Y; Zhang W
Aesthetic Plast Surg; 2018 Dec; 42(6):1519-1530. PubMed ID: 30083802
[TBL] [Abstract][Full Text] [Related]
11. Pain reduction by inducing sensory-motor adaptation in Complex Regional Pain Syndrome (CRPS PRISMA): protocol for a double-blind randomized controlled trial.
Halicka M; Vittersø AD; Proulx MJ; Bultitude JH
BMC Neurol; 2020 Feb; 20(1):62. PubMed ID: 32075590
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of botulinum A toxin for the treatment of chronic peripheral neuropathic pain: A systematic review of randomized controlled trials and meta-analysis.
Hary V; Schitter S; Martinez V
Eur J Pain; 2022 May; 26(5):980-990. PubMed ID: 35293078
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular botulinum toxin A (BtxA) in complex regional pain syndrome.
Kharkar S; Ambady P; Yedatore V; Schwartzman RJ
Pain Physician; 2011; 14(3):311-6. PubMed ID: 21587336
[TBL] [Abstract][Full Text] [Related]
14. Intramuscular botulinum toxin in complex regional pain syndrome: case series and literature review.
Kharkar S; Ambady P; Venkatesh Y; Schwartzman RJ
Pain Physician; 2011; 14(5):419-24. PubMed ID: 21927045
[TBL] [Abstract][Full Text] [Related]
15. Botulinum Toxin-A Injection in Chronic Pelvic Pain Syndrome Treatment: A Systematic Review and Pooled Meta-Analysis.
Panunzio A; Tafuri A; Mazzucato G; Cerrato C; Orlando R; Pagliarulo V; Antonelli A; Cerruto MA
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051002
[TBL] [Abstract][Full Text] [Related]
16. Symptom reduction and improved function in chronic CRPS type 1 after 12-week integrated, interdisciplinary therapy.
Elomaa M; Hotta J; de C Williams AC; Forss N; Äyräpää A; Kalso E; Harno H
Scand J Pain; 2019 Apr; 19(2):257-270. PubMed ID: 30789827
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type B: pH change reduces injection pain, retains efficacy.
Lowe PL; Lowe NJ
Dermatol Surg; 2014 Dec; 40(12):1328-33. PubMed ID: 25350125
[TBL] [Abstract][Full Text] [Related]
18. Treatment of complex regional pain syndrome type 1 in a pediatric patient using the lidocaine patch 5%: a case report.
Frost SG
Curr Ther Res Clin Exp; 2003 Sep; 64(8):626-9. PubMed ID: 24944409
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous botulinum toxin-A injection for treating postherpetic neuralgia.
Hu Y; Zou L; Qi X; Lu Y; Zhou X; Mao Z; Chen X; Liu K; Yang Y; Wu Z; Hu Y; Ma S
Dermatol Ther; 2020 Jan; 33(1):e13181. PubMed ID: 31769900
[TBL] [Abstract][Full Text] [Related]
20. Prevention of unfavourable effects of cigarette smoke on flap viability using botulinum toxin in random pattern flaps: An experimental study.
Karayel H; Kaya B; Caydere M; Terzioğlu A; Aslan G
Plast Surg (Oakv); 2015; 23(3):177-82. PubMed ID: 26361625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
